Objective: Endothelium-derived nitric oxide (EDNO) has been shown to have vascular, metabolic, and contractile effects in the heart. We evaluated these effects during intracoronary (i. before and after administration of the NO synthase inhibitor N -nitro-L-arginine methyl ester (L-NAME; 300 mg min for 15 min, i.c.). Results: Before L-NAME, CaCl caused dose-dependent, proportional increases in SS and MVO . Although CBF also increased, these 2 2 responses were less than proportional to those in MVO , and thus EO increased. L-NAME did not alter the cardiac effects of CaCl . 
Introduction
ical stimuli, including hypoxia [3] , reduced perfusion pressure (autoregulation) [4] , transient occlusion, i.e., Nitric oxide (NO) is produced in the vascular endoreactive hyperemia [5] , hypercapnia [6] , and the increased thelium from the amino acid L-arginine in a reaction cardiac work associated with tachycardia and increased catalyzed by NO synthase (NOS) and triggered by rises in wall tension [7] . Few studies have assessed the role of 11 intracellular Ca concentration [1] . Endothelium-derived EDNO in the myocardial functional hyperemia accom-NO (EDNO) diffuses to the underlying vascular smooth panying inotropic stimulation, and they were limited to muscle, where it stimulates guanylate cyclase and proagents that operate via the b-adrenergic receptor-cyclic duction of cyclic guanosine 39-59-monophosphate (cGMP), adenosine 39-59-monophosphate (cAMP) pathway, i.e., which has vasorelaxing effects [1] . EDNO is released isoproterenol and dobutamine [8] [9] [10] . tonically in the coronary circulation, and its release is Calcium is an inotropic agent that acts independently of accelerated by substances, e.g., acetylcholine, which operthe b-adrenergic receptor-cAMP pathway [11] . In a recent ate via specific receptors on the endothelial cell, and by study [12] , we assessed the coronary vascular effects mechanical factors, such as shear stress [2] . EDNO has accompanying CaCl -induced augmentations in contractili-2 been shown to play an important role in the reductions in ty in normal canine hearts. Intracoronary (i.c.) infusions of coronary vasomotor tone elicited by a variety of physiologCaCl were associated with increases in coronary blood 2 flow, although these increases were less than proportional to those in myocardial oxygen consumption. This sugly (model 413, Instrumentation Laboratories, Lexington, gested that a direct constricting effect for calcium partially MS). Muscle paralysis was achieved with an intravenous 21 antagonized the metabolic vasodilation associated with injection of vecuronium bromide, 0.1 mg kg with sup- 21 21 increased cardiac work [13] . The signal-transduction pathplements at 0.05 mg kg h . Body temperature was way underlying the coronary vasodilation during adminismaintained at 388C with a heating pad. Lactated Ringer's tration of CaCl remains to be clarified. A role for the solution was administered continuously at a rate of 5 2 11 21 21 NO-cGMP pathway is suggested by the ability of Ca ml kg h intravenously to compensate for evaporative concentration to modulate NOS activity in the endothelial fluid losses. Heparin (400 U / kg with supplementation) was cell (see above).
used for anticoagulation. The present study tested the hypothesis that EDNO The LAD was isolated for cannulation approximately 2 modulates the myocardial functional hyperemia during cm from its origin. A thin-wall stainless-steel cannula (2.5 administration of CaCl . This was evaluated by comparing mm inside diameter) was introduced into the isolated 2 the CaCl -induced changes in coronary blood flow before segment of the artery, so that it could be perfused 2 G and after treatment with the NOS inhibitor N -nitro-Lselectively by an extracorporeal perfusion system [6, 16] . arginine methyl ester (L-NAME). Recent in vitro studies
The perfusion system contained a pressurized reservoir, have suggested that EDNO may reduce myocardial oxygen which was supplied with blood from the left femoral consumption directly via inhibition of mitochondrial enartery. zymes [14] and indirectly via a negative inotropic effect
The tubing connecting the reservoir to the LAD was [15] . If NO has this influence in the intact heart during equipped with (1) a heat exchanger to maintain the exposure to CaCl , the increases in myocardial oxygen temperature of coronary arterial blood at 388C, (2) a 2 consumption may be accentuated following NOS inhibiDoppler flow transducer (Transonics Systems, Ithaca, NY) tion, thus providing an enhanced metabolic stimulus for to measure coronary blood flow, (3) ports for collecting coronary vasodilation. To distinguish between direct and samples of coronary arterial blood and for infusing drugs, metabolism-mediated effects of L-NAME on the myocarand (4) a mixing chamber for drugs infused into the dial functional hyperemic responses, the inotropically-inperfusion tubing. Coronary perfusion pressure was meaduced changes in coronary blood flow were assessed in the sured through a small-diameter tube positioned at the context of the concomitant changes in myocardial oxygen outlet of the perfusion cannula. consumption and segmental shortening.
Measurements of aortic pressure, heart rate, left atrial The study was performed using an extracorporeal syspressure, left ventricular 1dP/dt , and left ventricular max tem to perfuse selectively the left anterior descending 2dP/dt were obtained using standard methods [6, 16] 7 .3960.01). PO , PCO , and pH of arterial and venous the LAD cannula for collection of regional coronary 2 2 blood samples (see below) were measured electrometricalvenous effluent [17] . The venous cannula was allowed to drain freely into a beaker to prevent venous stagnation and previously to span a significant portion of the doseinterstitial edema. This venous blood was returned interresponse curve [18] . Isotonic saline was used to dilute 21 mittently to the dog to maintain isovolemic conditions. At CaCl to 5.0 mg ml , which resulted in infusion rates 2 21 specified times in the study, 1-ml blood samples were over the range 1.0 to 3.0 ml min . Preliminary studies collected from the coronary venous cannula under mineral demonstrated that infusion of the saline vehicle alone at oil to maintain anaerobic conditions. These venous samthese low flow rates had no effect on coronary blood flow ples were paired with 1-ml arterial samples from the or segmental shortening. After a final dose of CaCl , the 2 perfusion tubing, so that the coronary arteriovenous differinfusion pump was stopped and at least 20 min was ence for oxygen could be determined. Hemoglobin conallowed for recovery. Then L-NAME was infused at a rate 21 centration and percent hemoglobin oxygen saturation of of 300 mg min i.c. for 15 min to inhibit production of the blood samples were measured with a CO-Oximeter NO from the vascular endothelium [6, 10, 16] . Ten min (model 482, Instrumentation Laboratories, Lexington, MS), were allowed before the graded infusions of CaCl were 2 and used to calculate oxygen bound to hemoglobin assumrepeated. Efficacy of L-NAME was evaluated using i.c. ing an oxygen carrying capacity for hemoglobin of 1.39 ml infusions of the endothelium-dependent vasodilator acetyl- mm Hg) and added to the bound component to compute mg min ). The doses for ACh and SNP were the highest total oxygen content. Myocardial oxygen consumption (in that could be used without causing aortic hypotension 21 21 ml min 100 g ) was computed using the Fick equation, [6, 10, 16] . Vasodilator reserve was assessed with a max- i.e., from the product of the coronary arteriovenous oxygen imally-dilating infusion of adenosine (8 mg min i.c. difference and coronary blood flow. The myocardial [6, 10, 16] ). A coronary perfusion pressure of 80 mm Hg oxygen extraction (in %) was calculated by dividing the was used throughout the study. arteriovenous oxygen difference by the arterial oxygen At the termination of each experiment, 5 ml of Evans 21 content. These values are a reflection of the relationship blue dye (10 mg ml saline) was injected into the LAD to between myocardial oxygen consumption and coronary identify its perfusion territory. After the heart was stopped 21 blood flow [13] , and they served as an index of the with a 10-ml bolus injection of KCl (80 mg ml saline) effectiveness of metabolic vasodilation during CaCl . The into the left ventricular cavity, it was removed and 2 oxygen cost of inotropic stimulation was quantified by trimmed. The dyed tissue was excised and weighed so that dividing the inotropically-induced percentage increase in coronary blood flow could be expressed on a per 100-g myocardial oxygen consumption by the inotropically-inbasis. The average weight of the LAD perfusion territory duced percentage increase in segmental shortening. The was 3262 g. resultant value was termed the oxygen cost ratio. 11 
Statistical analyses 2.2.3. Coronary arterial ionized calcium concentration

Ionized calcium concentration ([Ca ]) in the LAD
A two-way analysis of variance for repeated measureblood during infusion of CaCl was estimated by calculatments was used to assess the dose-dependent effects of 2 11 ing the [Ca ] added to the blood (by dividing the CaCl before and after L-NAME [19] . Post hoc com-2 infusion rate for calcium by the steady state value for parisons were made using the Student's t-test with the coronary blood flow), and adding it to the control value for Bonferroni correction [19] . Additional statistical analyses
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[Ca ]. This approach was validated in our previous study were performed using the paired version of the Student's 11 [12] . The average value for measured [Ca ] under t-test [19] . Data are presented as mean6standard error. A control conditions in our previous study (1.2260.06 P,0.05 was considered significant throughout this study. 21 11 mmol l was used in the calculations of [Ca ] [12] .
Experimental protocols 3. Results
After .45 min for recovery from surgical preparation, Fig. 1 presents the effects of CaCl on coronary blood 2 control measurements for coronary blood flow, segmental flow, myocardial oxygen consumption, oxygen extraction, shortening, oxygen consumption and oxygen extraction and segmental shortening before and following L-NAME. were obtained. Then CaCl was infused into the LAD in a CaCl caused dose-dependent increases in coronary blood 2 2 21 graded fashion (5, 10, 15 mg min ). Measurements were flow, which at constant coronary perfusion pressure, obtained when steady state conditions were achieved at mirrored the induced decreases in coronary vascular each drug infusion rate (as indicated by stable increases in resistance. These increases in coronary blood flow were coronary blood flow and segmental shortening), which was less than proportional to those in myocardial oxygen within 2-3 min after varying the rate of infusion. The dose consumption, with the result that oxygen extraction inrange for CaCl was selected because it had been shown creased. CaCl caused dose-dependent increases in seg- (EO ), and segmental shortening (SS), before and after L-NAME. Findings were similar before and after L-NAME. Values are mean6SE. P,0.05. * vs. mental shortening, which were proportional to those in cardiac and systemic hemodynamic variables (Table 3) ; myocardial oxygen consumption; thus, oxygen cost ratio however, it blunted the increases in coronary blood flow by remained equal to unity (Table 1) . L-NAME had no ACh (178641% vs. 3966%), although it had no effect on independent effect on the local cardiac variables. There the increases in coronary blood flow by SNP (127617% was no interaction between the effects of CaCl and vs. 125614%) (Fig. 2) . Adenosine caused nearly five-fold 2 L-NAME.
increases in coronary blood flow (116615 to 564656 Table 2 shows that the values for calculated [Ca ] ml min 100 g ). varied directly with the rate of infusion of CaCl , and that Table 4 shows the effect of the i.c. infusions of CaCl 2 2 they were not different before and following L-NAME. before L-NAME on systemic hemodynamic and global L-NAME itself had no effect on the baseline values for cardiac variables. CaCl had no effect on these variables, 2 Table 1  Table 2 21
Values for the O cost ratio during graded intracoronary infusions of Calculated values for ionized calcium (mmol l ) in coronary blood 2 CaCl before and after L-NAME supply 2 [CaCl ] Pre L-NAME Post L-NAME [CaCl ] Pre L-NAME Post L-NAME Table 3 Baseline values for cardiac and systemic hemodynamic parameters before and following L-NAME Pre L-NAME Post L-NAME 21 21 Coronary blood flow, ml min 100 g 106611 104614 21 21 Myocardial oxygen consumption, ml min 100 g 6.260. 
Discussion
Critique of methods
The baseline values for oxygen extraction in the cannulated LAD bed were lower than those usually found in anesthetized dogs with an intact coronary circulation [20] . This suggests vasodilation in the control preparation probably because of dilators released from blood cells within the extracorporeal circuit [21] . Nevertheless, vascular responsiveness to both an endothelium-dependent vasodilator (ACh) and an endothelium-independent vasodilator (SNP) was pronounced (Fig. 2) . Moreover, vasodilator reserve was appreciable, as shown by the nearly five-fold increases in coronary blood flow during adenosine infusion. These latter findings indicated that the increases in coronary blood flow during CaCl administration were not 2 limited by the vasodilator reserve of the preparation. The ability of changes in segmental shortening to reflect coronary blood flow before and after L-NAME. L-NAME blunted the changes in myocardial contractility is limited by variations increases in coronary blood flow by ACh but not by SNP. Values are mean6SE. * vs. Before L-NAME.
in heart rate and in the loading conditions of the heart [22] . The constant values for heart rate and in indices of afterload (aortic pressure) and preload (left atrial pressure) during the i.c. infusions of CaCl and L-NAME suggest 2 with the exception that it increased left ventricular 1dP/ that this methodologic limitation did not apply to the dt . The responses were similar following L-NAME (data max present study. not shown).
Our baseline values for myocardial oxygen consumption Table 4 The intracoronary infusions of CaCl before L-NAME had no effect on systemic hemodynamic parameters, with the exception that they increased left 2 ventricular dP/dt . Findings were similar following L-NAME were typical of those obtained by us in this canine ing myocardial oxygen demand by local adjustments in preparation [6, 10, 12, 16] , but they were lower than those coronary vasomotor tone mediated by metabolic control reported by other investigators also studying open-chest, mechanisms [13] . This local control of coronary blood anesthetized dogs [7, 23] . This discrepancy may be due to flow tends to maintain coronary venous PO , and therefore 2 the lower, more physiological values, for heart rate when oxygen extraction, constant. The increases in oxygen fentanyl, rather than pentobarbital sodium, is used for extraction during administration of CaCl in the present 2 general anesthesia. Fentanyl reduces heart rate by stimulastudy reflected increases in coronary blood flow that were tion of vagal preganglionic neurons in the medulla [24] , less than proportional to the induced augmentations in whereas pentobarbital sodium increases heart rate via a myocardial oxygen consumption (secondary to calcium's vagolytic action [25] . Our baseline values for segmental positive inotropic effect). These findings are consistent shortening were well within the range of those previously with a direct vasoconstrictor effect for calcium, which was found in similar canine preparations [26, 27] .
capable of partially antagonizing, but not completely
11
[Ca ] in the coronary arterial blood during infusion of overriding, metabolic vasodilation. These findings in the CaCl was calculated by dividing the infusion rate for basal preparation confirm findings from our previous study 2 calcium by the steady state value for coronary blood flow, [12] .
and assuming a constant control value for [Ca ], i.e., that Our previous study in the same canine model using no recirculation of the infused calcium occurred. This dobutamine provides a reference for assessing the effects assumption was based on our previous finding indicating of CaCl [29] . Dobutamine caused increases in myocardial 2 11 only negligible increases in [Ca ] within the aortic blood contractility that were associated with proportional in-
21
during a high-dose (15 mg min ) infusion of CaCl into creases in myocardial oxygen consumption and coronary 2 the LAD [12] . The strong correlation between our calcublood flow with the result that oxygen extraction remained 11 lated values for [Ca ] and those measured directly [12] constant. These findings implied that metabolic control of 11 validated our approach for estimating [Ca ] in the coronary blood flow remained intact during dobutamine coronary arterial blood.
infusion, and thus that this agent had no direct vasomotor Intravenous infusions of NOS inhibitors cause increases effect on coronary resistance vessels [13] . They also ruled in systemic vascular resistance (and concomitant increases out the possibility that the increase in oxygen extraction in arterial pressure and left ventricular afterload) [1, 4] , (and the apparent direct vasoconstrictor effect) during suggesting that tonic release of NO may play an important CaCl was an obligatory response to inotropic stimulation 2 role in modulating basal vascular tone in the peripheral in our canine cardiac preparation. circulation. The use of i.c. infusions of L-NAME in the It has been established that endothelial NO synthase 11 present study avoided its systemic effects, which simplified (so-called constitutive NO synthase) is Ca -dependent, interpretation of the findings. Our i.c. dose for L-NAME and that production of EDNO is modulated by intracellular 11 was adopted from previous studies [6, 10, 16] , which Ca concentration [1] . Yet, we showed that L-NAME did showed that it produced a 70-80% attenuation of the not blunt the increases in coronary blood flow or alter their ACh-induced increases in coronary blood flow without relationship to myocardial oxygen consumption, i.e., the effects on systemic circulatory variables or on the inincreases in oxygen extraction, during CaCl , thus sug-2 creases in coronary blood flow caused by SNP. These gesting that EDNO did not contribute to the coronary findings were confirmed in the present study.
vasodilating response. We can propose two potential
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The residual ACh-induced increase in coronary blood explanations for this finding: (1) The increases in Ca flow following L-NAME raises the possibility that our dose concentration in the plasma were not reflected within the 11 for L-NAME was not adequate for a complete blockade of vascular endothelium. (2) The ability of Ca to modulate the NO-cGMP pathway. Although we cannot definitively EDNO production in the coronary resistance vessels, like rule this out, it seems unlikely since previous investigators that in isolated aortic segments [30], does not apply to using an i.c. dose for L-NAME four-times our dose (and concentrations above the physiological range. Of course, sufficient to cause increases in arterial pressure) reported we cannot rule out the possibility that EDNO was indeed similar results [8] . Indeed, the failure of NOS inhibitors, involved in the coronary vasodilating response during including L-NAME, to completely abolish ACh-induced CaCl , but that an alternate vasodilating factor, e.g., an 2 coronary vasodilation is a consistent finding in the literaaugmented adenosine release, compensated for its inhibiture [5] [6] [7] [8] [9] [10] 16, 23] , and it is likely explained by the ability tion. of ACh to cause release of a hyperpolarizing factor, in
The failure of NOS inhibition to reduce baseline coraddition to NO, from the vascular endothelium [28] .
onary blood flow has been demonstrated previously [5, 6, [8] [9] [10] 16, 31] , and it has been explained by the emergence of 4. [34] in a recent study in isolated ventricular myocytes, exercising, chronically instrumented dogs. The apparent showed that NO, in low concentrations, may paradoxically discrepancy between these findings and those from the increase myocardial contractility via its ability to inhibit present study may be attributable to methodological differcAMP phosphodiesterase, leading to increased levels of ences, including the absence or presence of general cAMP, and stimulation of cAMP-dependent protein kinase.
anesthesia, the route and dose of the NOS inhibitor, and Previous in vivo studies have consistently shown no the levels of myocardial oxygen consumption studied. influence of EDNO on contractility in non-stimulated Another factor may be the difficulty in distinguishing myocardium [16, 23, 31] , while some [15] , but not others changes in myocardial oxygen consumption due to direct [10] , have demonstrated a negative inotropic effect in effects on the mitochondria from those due to variations in myocardium stimulated with a b-receptor agonist. The the hemodynamic determinants of cardiac workload, e.g., present study extends these latter observations to myocarthe increases in aortic pressure, during exercise in the dium stimulated with CaCl . [16] . effect and a positive inotropic effect in the normal heart in Our findings pertain strictly to NO synthesized in the vivo. This vasoconstricting effect impaired coupling of coronary endothelium via the constitutive NOS pathway.
coronary blood flow to the augmented myocardial oxygen Another form of NOS (so-called inducible NOS) has been demand by metabolic vascular control mechanisms. (2) identified in a variety of cell types, e.g., neutrophils, EDNO did not modulate the increases in coronary blood vascular smooth muscle, and cardiac myocytes, following flow, myocardial oxygen consumption, or myocardial induction by immunological stimuli, such as cytokines and contractility during administration of CaCl . . Evidence for expression and activity of inducible following termination of cardiopulmonary bypass, when NOS has been obtained in myocardial samples from the generation of metabolic vasodilators, e.g., adenosine, patients with dilated cardiopathy, ischemic heart disease, may be decreased due to a diminished cardiac responsivevalvular heart disease, and cardiac allograft rejection [35- ness. This could unmask the coronary vasoconstricting 37]. Studies conducted in various isolated tissues, includaction of CaCl , which could precipitate myocardial 2 ing cardiac muscle slices and hepatocytes, have demonischemia. Our findings also imply that the myocardial strated that the elevated NO concentrations associated with functional hyperemia during CaCl should be normal in 2 the inducible NOS pathway may have a direct depressive the patient in which endothelial function is impaired effect on tissue oxygen use [14, 38, 39] . This effect has been because of chronic disease, e.g., atherosclerosis [42] , or attributed to the binding of NO to the heme moiety of acute insult, e.g., ischemia and reperfusion [43] . cytochrome enzymes in the mitochondrial electron-transport chain.
Recent studies have sought to determine whether this
